Great news, shows AFR have no clue what they are talking about! Share price would have been sub $2.35 if it was trading over the past few days anyway, so great timing, great vote of confidence by a group of experts who would have reviewed back pain results and are clearly impressed and positive msb will gain fda approval. They will be cheering when they gain shares at $2.88 and the share price is $60 a share in 2028
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-99
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.8¢ |
Change
0.003(0.27%) |
Mkt cap ! $1.059B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 92.5¢ | $799.2K | 858.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 328428 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 55065 | 29 |
View Market Depth
| Last trade - 14.46pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |